ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 172 filers reported holding ACCELERON PHARMA INC in Q3 2019. The put-call ratio across all filers is 1.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $73,600,000 | +190.5% | 575,271 | +155.5% | 0.45% | +32.5% |
| Q3 2020 | $25,335,000 | -60.3% | 225,146 | -66.4% | 0.34% | -31.3% |
| Q2 2020 | $63,780,000 | -99.8% | 669,467 | +53.7% | 0.49% | +37.0% |
| Q1 2020 | $36,594,594,000 | +5.0% | 435,624 | -33.8% | 0.36% | +54.1% |
| Q4 2019 | $34,868,073,000 | +134095.7% | 657,640 | 0.0% | 0.23% | +28.7% |
| Q3 2019 | $25,983,000 | -3.8% | 657,640 | 0.0% | 0.18% | -2.7% |
| Q2 2019 | $27,015,000 | -11.8% | 657,640 | 0.0% | 0.19% | -14.3% |
| Q1 2019 | $30,626,000 | +6.9% | 657,640 | 0.0% | 0.22% | -10.3% |
| Q4 2018 | $28,640,000 | -23.9% | 657,640 | 0.0% | 0.24% | -10.4% |
| Q3 2018 | $37,636,000 | +18.0% | 657,640 | 0.0% | 0.27% | +7.6% |
| Q2 2018 | $31,908,000 | -13.5% | 657,640 | -30.2% | 0.25% | -12.5% |
| Q1 2018 | $36,893,000 | -7.8% | 942,844 | 0.0% | 0.29% | -32.6% |
| Q4 2017 | $40,014,000 | – | 942,844 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |